Netherlands· NL-e148b4557d5a
Timolol Sandoz 2,5 mg/ml, oogdruppels
A timolol product containing timololmaleaat, registered in Netherlands by Sandoz B.V.. The same ATC class is registered in 14 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Timolol is registered in 14 of 19 countries.
Countries holding a registration under ATC S01ED01 (timolol), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 9 of them publish a price we can compare per daily dose
Timolol · ATC S01ED01
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of timolol costs, country by country.
Normalised to the WHO defined daily dose (0.2 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Timolol · price per daily dose (0.2 g)
USD · FX 28 Sept 2026
- IT Italy$2.87
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- TIMOLOLMALEAAT
- Manufacturer
- Sandoz B.V.
- Country
- Netherlands (NL)
- ATC code
- S01ED01
- ATC class
- Timolol
- Defined daily dose
- 0.2 g, AS
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id57608
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
144 interactions on record for timolol.
Graded by severity as the source publishes them — 28 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Timolol · interactions on record
144 records
- 28 severe
- 114 moderate
- 2 minor
Most severe, free to view
- EpinephrineB02BC09severe
- EpinephrineC01CA24severe
- OrciprenalinC01CA29severe
- TheophyllinC01EB28severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Timolol in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United Statestimolol maleateLifestar Pharma LLC
- FinlandAquanilOmniVision AB
- BelgiumTimoptol 2,50 mg/ml (0,25 %)Santen
- FranceOPHTIM 0,25 POUR CENT (0,625 mg/0,25 ml), collyre en récipient unidoseTHEA
- PolandOftensinZakłady Farmaceutyczne POLPHARMA S.A.
- United KingdomBetim 10mg tabletsLexon (UK) Ltd
- ItalyBLOCADREN*40 cpr 10 mgSIT LABORATORIO FARMAC. Srl
- GermanyArutimol®Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Timoftal, Timolol Micro Labs
- Belgium · Geltim, Timabak
- Bulgaria · Гелтим, Кузимолол
- Cyprus · Lithimole
- Czechia · Oftan, Timo-Comod
- Germany · Dispatim, Gelisia
- Denmark · Eyopto, Optimol
- Estonia · Timosan
- Spain · Cusimolol, Gelisia
- Finland · Oftan Timolol, Timosan
- France · Geltim Lp, Genoptol
- United Kingdom (Northern Ireland) · Eysano, Timolol Blumont Pharma
- Greece · Geltim, Lithimole
- Croatia · Timalen
- Hungary · Cusimolol
- Ireland · Timofluid, Timolol Brown & Burk Ir
- Iceland · Timosan Depot
- Italy · Blocadren, Cusimolol
- Lithuania · Oftan, Timosan
- Luxembourg · Dispatim, Geltim
- Latvia · Oftan Timolol, Timosan
- Malta · Lithimole
- Norway · Oftan, Timosan
- Poland · Cusimolol, Timo-Comod 0,5 %
- Portugal · Dibetop, Timabak
- Romania · Gelisia, Geltim
- Sweden · Optimol, Timosan
- Slovenia · Timalen, Timoptic -Xe
- Slovakia · Unitimolol
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cd413932-88c7-4d07-9fa9-29189715e05b GET /v1/drugs/cd413932-88c7-4d07-9fa9-29189715e05b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oogdruppels, oplossing",
"route": "Oculair gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h57608_smpc.pdf",
"strength": null,
"atc_label": "Timolol",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg57608",
"excipients": [
"BENZALKONIUMCHLORIDE",
"DINATRIUMWATERSTOFFOSFAAT 12-WATER (E 339)",
"NATRIUMDIWATERSTOFFOSFAAT 2-WATER (E 339)",
"WATER, GEZUIVERD"
],
"substances": [
"TIMOLOLMALEAAT"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h57608.pdf",
"authorised_at": "1995/11/29",
"procedure_number": null,
"dispensing_status": "Uitsluitend recept",
"registration_number": "57608",
"additional_monitoring": "N"
}See everything about timolol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.